Archive for the ‘Treatment’ Category
PREVENTATIVE BRAIN RADIATION FOR LUNG CANCER
November 12th, 2009
nospam@example.com (Clear the Smoke) wrote an intriguing post today on
Here’s a little taster
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Study results show that while preventative brain radiation for patients with non-small cell lung cancer – the most common form of lung cancer – does reduce the chance of developing brain metastases, it impacts some short-term and long-term memory.
Read the rest of this post here
Posted in 
“The New Face Of Lung Cancer: Personalized Medicine”
November 6th, 2009
sam wrote an intriguing post today on
Here’s a little taster
Winthrop-University Hospital’s Advances in Cancer Care educational series will offer a free program, “The New Face of Lung Cancer: Personalized Medicine,” on Tuesday, November 10, 2009, at 7:00 PM. It will be held at Winthrop’s Community Outreach Center, located at 101 Mineola Boulevard at the corner of Second Street in Mineola.
Jeffrey Schneider, MD, Director of the Lung Cancer Center at Winthrop, will explain a new approach to personalized treatment and how it promises to provide meaningful breakthroughs for patients.
Read the rest of this post here
Lung cancer vaccine being tested in Europe
August 21st, 2009
Hope for people suffering from lung cancer
August 21st, 2009
nospam@example.com (Clear the Smoke) wrote an intriguing post today on
Here’s a little taster
Serbia is the first country in Europe to test the vaccine against lung cancer. Presently the effects of the vaccine are being tested on four patients at ‘Bezanijska Kosa’ hospital. It is being given to patients after the treatment. They have already undergone the first chemotherapy that led to stabilization of the disease or its complete withdrawal.
Read the rest of this post here
The human placenta releases substances that drive lung cancer into apoptosis
August 21st, 2009
Debi wrote an intriguing post today on
Here’s a little taster
As there is no optimal treatment of non small cell lung cancer due to its resistance to common chemotherapeutics, we investigated the effect of human placenta-conditioned medium on tumor tissue. The human placenta constitutes a mixture of maternal and fetal origin and displays a variety of immunomodulatory aspects.
Read the rest of this post here
Study: Lung cancer pill works for some patients
August 19th, 2009
nospam@example.com (Clear the Smoke) wrote an intriguing post today on
Here’s a little taster
Four years after the government severely restricted its use, the lung cancer drug Iressa may be poised to make a comeback: A study concludes it can slow the deadly disease better than standard chemotherapy in certain patients.
Read the rest of this post here
Avastin wows again in breast cancer trial as second-line agent
August 19th, 2009
Debi wrote an intriguing post today on
Here’s a little taster
Roche’s flagship cancer drug Avastin won yet another gold star yesterday after performing well in a late stage trial assessing its potential in extending progression free survival in women with breast cancer.
Currently, the drug is approved on both sides of the Atlantic as a treatment for colorectal cancer, non-small lung cancer, renal cell carcinoma and as a first-line therapy for breast cancer, while in the US it has also been cleared for glioblastoma.
Read the rest of this post here
‘Trojan horse’ drug shows cancer benefit
August 11th, 2009
Debi wrote a pretty interesting post today on
Here’s an excerpt for you
A drug that takes advantage of cancer cells’s appetite for the vitamin folate helped keep lung cancer at bay in 30 percent of patients with advanced disease, the chief executive of Endocyte said on Monday.
Read the rest of their post here here
Sirnaomics Receives NCI Grant to Develop siRNA-Based Lung Cancer Rx
July 23rd, 2009
nospam@example.com (Clear the Smoke) wrote a good post today on
Here’s a little excerpt
Sirnaomics this week announced that it has received a Small Business Innovation Research grant from the National Cancer Institute to develop novel siRNA-based therapeutics for lung cancer.
Read the rest of this great post here
Drug Combination Helps Patients with Advanced Lung Cancer
July 23rd, 2009
Debi wrote a good post today on
Here’s a little excerpt
A study examining erlotinib-bevacizumab combination therapy in patients with advanced non-small cell lung cancer (NSCLC) suggests that disease progression can be delayed with this therapy.
These findings were presented by Vincent Miller, MD at the 2009 Annual Meeting of the American Society of Clinical Oncology.
Read the rest of this great post here